Insomnia remains one of the most common sleep disorders globally, affecting millions of individuals across different age groups. Despite multiple treatment options such as benzodiazepines, melatonin receptor agonists, and antihistamines, the unmet clinical need continues to expand. With 10–30% of adults experiencing sleep difficulties and the prevalence rising to as high as 48% in older...